LFMD vs MEDS
Loading...
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFMD is a Hold and MEDS is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
LFMD’s FA Score shows that 0 FA rating(s) are green whileMEDS’s FA Score has 0 green FA rating(s).
- LFMD’s FA Score: 0 green, 5 red.
- MEDS’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
LFMD’s TA Score shows that 4 TA indicator(s) are bullish while MEDS’s TA Score has 5 bullish TA indicator(s).
- LFMD’s TA Score: 4 bullish, 4 bearish.
- MEDS’s TA Score: 5 bullish, 3 bearish.
Price Growth
LFMD (@Packaged Software) experienced а -16.99% price change this week, while MEDS (@Drugstore Chains) price change was -9.65% for the same time period.
The average weekly price growth across all stocks in the @Packaged Software industry was +1.87%. For the same industry, the average monthly price growth was +4.67%, and the average quarterly price growth was +23.22%.
The average weekly price growth across all stocks in the @Drugstore Chains industry was -1.41%. For the same industry, the average monthly price growth was +1.02%, and the average quarterly price growth was -0.19%.
Reported Earning Dates
LFMD is expected to report earnings on Aug 08, 2024.
MEDS is expected to report earnings on Jul 24, 2023.
Industries' Descriptions
@Packaged Software (+1.87% weekly)Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.
@Drugstore Chains (-1.41% weekly)The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.
| LFMD | MEDS | LFMD / MEDS | |
| Capitalization | 399M | 12.3M | 3,244% |
| EBITDA | -7.89M | -2.68M | 294% |
| Gain YTD | -6.876 | 48.813 | -14% |
| P/E Ratio | N/A | N/A | - |
| Revenue | 153M | 10.5M | 1,457% |
| Total Cash | 33.1M | 34K | 97,353% |
| Total Debt | 18.9M | 6.48M | 292% |
LFMD | MEDS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 56 | 2 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 90 Overvalued | 98 Overvalued | |
PROFIT vs RISK RATING 1..100 | 72 | 100 | |
SMR RATING 1..100 | 100 | 98 | |
PRICE GROWTH RATING 1..100 | 38 | 39 | |
P/E GROWTH RATING 1..100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | 35 | 95 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
LFMD's Valuation (90) in the null industry is in the same range as MEDS (98). This means that LFMD’s stock grew similarly to MEDS’s over the last 12 months.
LFMD's Profit vs Risk Rating (72) in the null industry is in the same range as MEDS (100). This means that LFMD’s stock grew similarly to MEDS’s over the last 12 months.
MEDS's SMR Rating (98) in the null industry is in the same range as LFMD (100). This means that MEDS’s stock grew similarly to LFMD’s over the last 12 months.
LFMD's Price Growth Rating (38) in the null industry is in the same range as MEDS (39). This means that LFMD’s stock grew similarly to MEDS’s over the last 12 months.
LFMD's P/E Growth Rating (100) in the null industry is in the same range as MEDS (100). This means that LFMD’s stock grew similarly to MEDS’s over the last 12 months.
| LFMD | MEDS | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 78% | 1 day ago 78% |
| Stochastic ODDS (%) | 1 day ago 89% | 1 day ago 86% |
| Momentum ODDS (%) | 1 day ago 84% | N/A |
| MACD ODDS (%) | 1 day ago 89% | 1 day ago 78% |
| TrendWeek ODDS (%) | 1 day ago 87% | 1 day ago 87% |
| TrendMonth ODDS (%) | 1 day ago 87% | 1 day ago 88% |
| Advances ODDS (%) | 4 days ago 88% | 1 day ago 81% |
| Declines ODDS (%) | 1 day ago 85% | 2 days ago 90% |
| BollingerBands ODDS (%) | 1 day ago 83% | 4 days ago 90% |
| Aroon ODDS (%) | N/A | 1 day ago 90% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PICMX | 62.33 | -0.04 | -0.06% |
| Virtus KAR Mid-Cap Growth I | |||
| FQTEX | 12.51 | -0.01 | -0.08% |
| Franklin Templeton SMACS: Series E Adv | |||
| CADVX | 17.55 | -0.03 | -0.17% |
| Calamos Dividend Growth A | |||
| TILPX | 26.58 | -0.12 | -0.45% |
| Nuveen Large Cap Growth Premier | |||
| RSEGX | 56.06 | -0.81 | -1.42% |
| Victory RS Small Cap Growth A | |||
LFMD and
Correlation & Price change
A.I.dvisor tells us that LFMD and PAGS have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFMD and PAGS's prices will move in lockstep.
| Ticker / NAME | Correlation To LFMD | 1D Price Change % | ||
|---|---|---|---|---|
| LFMD | 100% | -7.10% | ||
| PAGS - LFMD | 29% Poorly correlated | +0.31% | ||
| LYFT - LFMD | 29% Poorly correlated | -0.76% | ||
| CRNC - LFMD | 29% Poorly correlated | +0.82% | ||
| STNE - LFMD | 28% Poorly correlated | -1.43% | ||
| COMP - LFMD | 27% Poorly correlated | -1.36% | ||
More | ||||
MEDS and
Correlation & Price change
A.I.dvisor tells us that MEDS and LFMD have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MEDS and LFMD's prices will move in lockstep.
| Ticker / NAME | Correlation To MEDS | 1D Price Change % | ||
|---|---|---|---|---|
| MEDS | 100% | -2.01% | ||
| LFMD - MEDS | 22% Poorly correlated | -7.10% | ||
| PETS - MEDS | 7% Poorly correlated | +1.43% | ||
| LFLY - MEDS | 5% Poorly correlated | +6.38% | ||
| SSY - MEDS | 4% Poorly correlated | -0.05% | ||
| YI - MEDS | 4% Poorly correlated | +3.08% | ||
More | ||||